-
公开(公告)号：US20060251705A1
公开(公告)日：2006-11-09
申请号：US11418999
申请日：2006-05-05
IPC分类号： A61K31/727 , A61K31/65 , A61K9/70
CPC分类号： A61K31/65 , A61K9/0019 , A61K31/727 , A61K47/12 , A61K47/26 , A61K2300/00
摘要： The present disclosure is directed to combination therapies of tigecycline and heparin and methods of administration of tigecycline and heparin.
摘要翻译： 本公开涉及替加环素和肝素的联合疗法以及给予替加环素和肝素的方法。
-
公开(公告)号：US08524281B2
公开(公告)日：2013-09-03
申请号：US12940797
申请日：2010-11-05
申请人： Sripriya Venkata Ramana Rao , Syed Muzafar Shah , Christopher Richard Diorio , Maja Vencl-Joncic , Eugene James Murphy
发明人： Sripriya Venkata Ramana Rao , Syed Muzafar Shah , Christopher Richard Diorio , Maja Vencl-Joncic , Eugene James Murphy
IPC分类号： A61K31/4709 , A61K35/00
CPC分类号： A61K9/5073 , A61K9/5026 , A61K31/4709
摘要： The present invention provides an oral pharmaceutical formulation comprising coated spheroids of a kinase inhibitor such as neratinib, which formulation is designed to reduce or eliminate side effects associated with existing oral formulations of kinase inhibitors.
-
3.发明申请COATED DRUG SPHEROIDS AND USES THEREOF FOR ELIMINATING OR REDUCING CONDITIONS SUCH AS EMESIS AND DIARRHEA 有权涂层药物及其用于消除或减少诸如EMESIS和DIARRHEA等条件的用途公开(公告)号：US20110165257A1
公开(公告)日：2011-07-07
申请号：US12940797
申请日：2010-11-05
申请人： Sripriya Venkata Ramana Rao , Syed Muzafar Shah , Christopher Richard Diorio , Maja Vencl-Joncic , Eugene Murphy
发明人： Sripriya Venkata Ramana Rao , Syed Muzafar Shah , Christopher Richard Diorio , Maja Vencl-Joncic , Eugene Murphy
IPC分类号： A61K31/4709 , A61K9/14 , A61P35/00
CPC分类号： A61K9/5073 , A61K9/5026 , A61K31/4709
摘要： The present invention provides an oral pharmaceutical formulation comprising coated spheroids of a kinase inhibitor such as neratinib, which formulation is designed to reduce or eliminate side effects associated with existing oral formulations of kinase inhibitors.
摘要翻译： 本发明提供了包含激酶抑制剂例如那赫那定的包被球体的口服药物制剂，该制剂设计用于减少或消除与现有的激酶抑制剂的口服制剂相关的副作用。
-
-
搜索结果
3 条记录 (耗时 0.01 秒)
